Raimundo García

703 total citations
8 papers, 279 citations indexed

About

Raimundo García is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Raimundo García has authored 8 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 3 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Raimundo García's work include Acute Myeloid Leukemia Research (4 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Cancer therapeutics and mechanisms (2 papers). Raimundo García is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Cancer therapeutics and mechanisms (2 papers). Raimundo García collaborates with scholars based in Spain, United Kingdom and United States. Raimundo García's co-authors include Jesús F. San Miguel, A Parreira, Júlia Almeida, Francisco Ruiz‐Cabello, Alberto Órfão, Clara Bueno, Fernando Ramos, Paulo Lúcio, Dimas Suárez‐Vilela and Miguel Á. Sanz and has published in prestigious journals such as Blood, British Journal of Haematology and Leukemia.

In The Last Decade

Raimundo García

8 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raimundo García Spain 7 163 93 75 67 53 8 279
Morgan Mace United States 4 244 1.5× 84 0.9× 42 0.6× 36 0.5× 158 3.0× 8 351
Ian H Gabriel United Kingdom 7 146 0.9× 85 0.9× 115 1.5× 102 1.5× 30 0.6× 14 399
Fabio Guolo Italy 10 112 0.7× 127 1.4× 16 0.2× 37 0.6× 78 1.5× 46 306
Costas K. Yannakou Australia 9 63 0.4× 133 1.4× 32 0.4× 129 1.9× 44 0.8× 41 325
R André Switzerland 8 63 0.4× 43 0.5× 61 0.8× 29 0.4× 30 0.6× 63 260
Yoshinari Kawabata Japan 9 182 1.1× 129 1.4× 23 0.3× 32 0.5× 96 1.8× 19 415
Jong‐Ding Lay Taiwan 8 244 1.5× 195 2.1× 39 0.5× 43 0.6× 98 1.8× 13 521
Emilie C. Bright United States 11 352 2.2× 86 0.9× 30 0.4× 36 0.5× 52 1.0× 24 589
Tatiana Lawrence United States 10 68 0.4× 90 1.0× 18 0.2× 39 0.6× 47 0.9× 26 323
R M Y Barge Netherlands 6 209 1.3× 96 1.0× 21 0.3× 49 0.7× 31 0.6× 7 438

Countries citing papers authored by Raimundo García

Since Specialization
Citations

This map shows the geographic impact of Raimundo García's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raimundo García with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raimundo García more than expected).

Fields of papers citing papers by Raimundo García

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raimundo García. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raimundo García. The network helps show where Raimundo García may publish in the future.

Co-authorship network of co-authors of Raimundo García

This figure shows the co-authorship network connecting the top 25 collaborators of Raimundo García. A scholar is included among the top collaborators of Raimundo García based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raimundo García. Raimundo García is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Bergua, Juan, Pau Montesinos, Pascual Fernández, et al.. (2016). A prognostic model for survival after salvage treatment with FLAG‐Ida +/− gemtuzumab‐ozogamicine in adult patients with refractory/relapsed acute myeloid leukaemia. British Journal of Haematology. 174(5). 700–710. 36 indexed citations
2.
Bergua, Juan, Pau Montesinos, David Martínez‐Cuadrón, et al.. (2014). A Prognostic Index for Patients with Refractory or in First Relapsed Acute Myeloid Leukemia Treated with FLAG-Ida or Flago-Ida. Blood. 124(21). 1049–1049. 1 indexed citations
3.
Piñana, José Luís, Pau Montesinos, Rodrigo Martino, et al.. (2013). Incidence, risk factors, and outcome of bacteremia following autologous hematopoietic stem cell transplantation in 720 adult patients. Annals of Hematology. 93(2). 299–307. 32 indexed citations
4.
Rubia, Javier de la, Pau Montesinos, Rodrigo Martino, et al.. (2009). Imipenem/Cilastatin with or without Glycopeptide as Initial Antibiotic Therapy for Recipients of Autologous Stem Cell Transplantation: Results of a Spanish Multicenter Study. Biology of Blood and Marrow Transplantation. 15(4). 512–516. 6 indexed citations
5.
Suela, Javier, Sara Álvarez, Francisco Tejada Cifuentes, et al.. (2007). DNA profiling analysis of 100 consecutive de novo acute myeloid leukemia cases reveals patterns of genomic instability that affect all cytogenetic risk groups. Leukemia. 21(6). 1224–1231. 38 indexed citations
6.
Carreras, Enric, Laura Rosiñol, María José Terol, et al.. (2007). Veno-Occlusive Disease of the Liver after High-Dose Cytoreductive Therapy with Busulfan and Melphalan for Autologous Blood Stem Cell Transplantation in Multiple Myeloma Patients. Biology of Blood and Marrow Transplantation. 13(12). 1448–1454. 60 indexed citations
7.
Bueno, Clara, Júlia Almeida, Paulo Lúcio, et al.. (2004). Incidence and characteristics of CD4(+)/HLA DRhi dendritic cell malignancies.. PubMed. 89(1). 58–69. 87 indexed citations
8.
Sempere, Amparo, Javier Palau, Raimundo García, et al.. (1993). Acute Myeloblasts Leukemia with Minimal Myeloid Differentiation (FAB AML-M0): A Study of Eleven Cases. Leukemia & lymphoma. 12(1-2). 103–108. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Morgan Mace Breakdown of academic impact, for papers by Ian H Gabriel Breakdown of academic impact, for papers by Fabio Guolo Breakdown of academic impact, for papers by Costas K. Yannakou Breakdown of academic impact, for papers by R André Breakdown of academic impact, for papers by Yoshinari Kawabata Breakdown of academic impact, for papers by Jong‐Ding Lay Breakdown of academic impact, for papers by Emilie C. Bright Breakdown of academic impact, for papers by Tatiana Lawrence Breakdown of academic impact, for papers by R M Y Barge
Rankless by CCL
2026